ArticleBMC women's health2023
What do I do to avoid sexually transmitted diseases? A scale development study: behavioral scale for protection from sexually transmitted diseases.
Article in BMC women's health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and psychometric evaluation of the stigma scale for caring for individuals with sexually transmitted infections (STISS)- student version.BMC infectious diseases · 2026Article
- The mediating role of human papillomavirus concern in the relationship between human papillomavirus knowledge and preventive behaviors against sexually transmitted diseases among Turkish women with higher education.Revista da Associacao Medica Brasileira (1992) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The authors' aim is to develop and confirm a reliable and valid measurement tool that can measure women's behavior to prevent sexually transmitted diseases. The study data were collected from adult women aged 18-47 years (n = 505). Explanatory factor analysis (EFA) was applied to the STD scale consisting of 44 items in a 5-point Likert style. According to the results of EFA, 21 items were defined in the scale. The KMO value of the scale is 90.6%. In the study, the varimax rotation method was used to bring the factors together with the related items. As a result of varimax rotation, two factors with eigenvalues greater than 1 were found in the scale. The overall Cronbach's alpha coefficient of the scale was calculated as 0.911, 0.941 for the first subdimension and 0.889 for the second subdimension. The validity and reliability of this study have been proven according to the results of explanatory factor analysis (EFA) and confirmatory factor analysis (CFA).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.